Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ciclesonide/formoterol

Next Previous
Drug Profile

Ciclesonide/formoterol

Alternative Names: BY9010/M-1506; Ciclesonide/formoterol fumarate; Formoterol/ciclesonide

Latest Information Update: 20 Jul 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nycomed
  • Developer Sumitomo Pharma America; Takeda Pharmaceuticals International GmbH
  • Class Antiasthmatics; Bronchodilators; Ethanolamines; Pregnenediones; Small molecules
  • Mechanism of Action Arachidonic acid inhibitors; Beta 2 adrenergic receptor agonists; Immunosuppressants; Lipocortin synthesis agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 30 Sep 2011 Nycomed has been acquired by Takeda
  • 12 Oct 2010 Sepracor is now called Sunovion Pharmaceuticals
  • 20 Oct 2009 Sepracor has been acquired by Dainippon Sumitomo Pharma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top